Base to Base biotech podcast 50: Drugs for kidney transplants, glycans, and  drug delivery
Anti-cancer drug gets phase I FDA trials approval
New mass spec platform launched
Approval for prostate cancer treatment
FDA clearance for refractory systemic lupus erythematosus CAR-T cell therapy
Novel gene therapy for ALS cleared for trials in US and China
Positive phase 2 results from Stargardt disease study
Researchers re-engineer AI language model to target previously ‘undruggable’ disease proteins
Kexing Biopharm partners with IQVIA to expand globally
ThinkBio.Ai and UST partner to help biopharma and healthcare
ChronicleBio aims to accelerate breakthroughs for millions living with complex chronic conditions
Base to Base biotech podcast 22: A new treatment for dry AMD and tackling peanut allergies